gallagher carol giltner  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address co atara biotherapeutics inc  gateway boulevard suite  south san francisco ca   results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg pretpwinssretswins filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadsdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadmdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadsdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadmdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadsdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadmdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadsdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadmdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadmdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadsdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadmdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadsdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadmdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadsdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadsmd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadmdd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadsdmd  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadpi  atraatara biotherapeutics incdehealthbioprdbiological products no diaggallagher carol giltnercadpdd dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved atra carol giltner gallagher insider trades for atara biotherapeutics inc bulletin investor alert new york markets after hours market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close atara biotherapeutics inc nasdaq atra go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus atara biotherapeutics inc after hours  quotes are delayed by  min jul    pm atra quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   insider activity individual carol giltner gallagher dr carol g gallagher is partner at new enterprise associates llc executive chairman at atara biotherapeutics inc executive chairman at anaptysbio inc and chairman at millendo therapeutics inc she is on the board of directors at seragon pharmaceuticals inc and sharp healthcare dr gallagher was previously employed as venture partner by frazier management llc chairman by effector therapeutics inc president  chief executive officer by calistoga pharmaceuticals inc president  chief executive officer by metastatix inc svpcorporate development  commercial affairs by anadys pharmaceuticals inc vice presidentproduct planning by cancervax corp senior directoroncology marketing by biogen idec inc vice presidentsales  marketing by amgen inc vice presidentsales  marketing by eli lilly  co vice presidentsales  marketing by agouron pharmaceuticals inc rituxan development team leader by idec pharmaceuticals corp and directorglobal marketing planning by pfizer inc she also served on the board at aragon pharmaceuticals inc dr gallagher received his undergraduate degree from the university of kentucky college of pharmacy and a doctorate degree from the university of kentucky college of pharmacy transactions date shares transaction value     disposition at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      acquisition at  per share      acquisition at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr issac e ciechanover chairman president  chief executive officer mr john f mcgrath chief financial officer  secretary dr christopher m haqq chief medical  scientific officer mr derrell porter senior vice president  global headcommercial mr joe newell chief technical operations officer  executive vp mr gad soffer chief strategy officer  executive vice president mr william k heiden director mr steve bertram headglobal human resources mr mitchall g clark chief regulatory  quality assurance officer dr carol giltner gallagher lead independent director mr matthew k fust independent director mr eric l dobmeier independent director dr beth c seidenberg independent director mr joel s marcus independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest palphabet falls after earnings beat live blog phere’s a sign investors are viewing earnings through rosetinted glasses pmcdonald’s earnings sales expected to be boosted by menu franchisee changes ptrump today president asks why ‘beleaguered’ sessions isn’t probing clinton pargentina etf sees steep outflows amid strong gains pbacktoschool shopping is no longer just for parents and their kids palphabet reports secondquarter earnings beat p of the best places to see the ‘great american eclipse’ on aug  pbreakingdow sp  end lower as nasdaq books st record of  palphabet shares down  palphabet q revenue  billion vs  billion factset consensus  billion palphabet q eps  vs  factset consensus  ptrump administration stymies push for improved climaterisk disclosure among companies pcalmaine says egg production has recovered from avian flu but demand hasn’t phere’s what it looks like when the foreclosure ‘pig’ moves through the housingcrisis ‘python’ pbreakingsp  dow industrials close modestly lower pnasdaq composite ends at record after small gain p‘game of thrones’ the four biggest takeaways from stormborn’ palphabet earnings a  billion hit for google potential youtube results for investors pthe biggest financial bloggers reveal their positions on bitcoin and cryptocurrencies loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  carol giltner gallagher  del mar ca  intelius sign in we found carol giltner gallagher in del mar ca carol giltner gallagher intelius found that carol giltner gallagher is a female between  and  years old from del mar ca we have connected them to  addresses  phones and  relatives or associates also known as carolyn leigh giltner carol leigh giltner carolyn a giltner c l gallagher c l giltner get report now age carol giltner gallagher is in her s carol has lived in del mar ca south san francisco ca la jolla ca carols relatives john gallagher bill giltner willam giltner carol giltner gallagher zodiac signgemini genderfemale professional status partner at national endowment for the arts get report now want to know more about carol get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about carol or use our people search engine to find others get background check on carol giltner gallagher get a criminal check on carol giltner gallagher get a public record report on carol giltner gallagher get a people search report on carol giltner gallagher carol giltner gallaghers contact information known cities lived in find out where carol giltner gallagher has lived as well as carol giltner gallaghers phone numbers and email addresses carol giltner gallagher has lived in  states california address for carol giltner gallagher  v w del mar ca has lived in del mar ca south san francisco ca get full address report phone numbers associated with carol giltner gallagher    eminence ky    atlanta ga    shelbyville ky get full phone report email addresses associated with carol giltner gallagher jmcom crnet crcom get email report carol giltner gallaghers education information known schools attended learn about carol giltner gallaghers academic history find out which schools carol giltner gallagher attended the dates attended as well as the degrees carol giltner gallagher received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act carol giltner gallagher has attended  schools vanderbilt university carol giltner gallagher has a chemistry college of pharmacy at the university of kentucky college of pharmacy at the university of kentucky university of kentucky university of kentucky college of arts and sciences at vanderbilt university carol giltner gallaghers professional information information regarding carol giltner gallaghers professional history find out previous places carol giltner gallagher has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act carol giltner gallagher has worked at  places company national endowment for the arts title partner company new enterprise associates ltd title partner carol giltner gallaghers experience title partner company national endowment for the arts job details about the national endowment for the arts the national endowment for the arts is a public agency dedicated to supporting excellence in the arts both new and established bringing the arts to all americans and providing leadership in arts education established by congress in  as an independent agency of the federal government the endowment is the nations largest annual funder of the arts bringing great art to all  states including rural areas inner cities and military bases title partner company new enterprise associates ltd job details nea is a leading venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages sectors and geographies with about  billion in committed capital the firm invests in information technology healthcare and energy technology companies at all stages in a companys lifecycle from seed stage through ipo neas long track record of successful investing includes more than  portfolio company ipos and more than  acquisitions including investments in technology leaders like advertisingcom data domain careerbuilder diaperscom fusionio groupon juniper macromedia millennial media salesforcecom and tivo additional professional information on carol giltner gallagher see carol giltner gallaghers linkedin profile carol giltner gallaghers social network and potential email matches find out potential social network profiles and potential email usernamed for carol giltner gallagher carol giltner gallaghers known social networks and potential email matches find all of carol giltner gallaghers social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches carol gallagher username matches carolgallagher gallaghercarol carolgallagher gallaghercarol carolgallagher gallaghercarol carolgallagher gallaghercarol cgallagher popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches c gallagher intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here carol giltner gallagher phd  biography log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east� more equities indexes dow jonessp nasdaq tsx compftse � more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd� more currencies commodities goldcrude oil wticrude oil brentsilverplatinum� more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    news    business leaders    business leaders biography business leaders latest newscompaniesmarketseconomy  forexcommoditiesinterest ratesbusiness leadersfinance professionalscalendarsectors homeall newsmost read newsbusiness leaders biography carol giltner gallagher phd age  public asset   usdlinked companies  anaptysbio inc  atara biotherapeutics inc summary  dr carol g gallagher is partner at new enterprise associates llc executive chairman at anaptysbio inc and chairman at millendo therapeutics incshe is on the board of directors at atara biotherapeutics inc sharp healthcare and sanford burnham prebys medical discovery institute dr gallagher was previously employed as venture partner by frazier management llc chairman by effector therapeutics inc president  chief executive officer by calistoga pharmaceuticals inc president  chief executive officer by metastatix inc svpcorporate development  commercial affairs by anadys pharmaceuticals inc vice presidentproduct planning by cancervax corp senior directoroncology marketing by biogen idec inc vice presidentsales  marketing by amgen inc vice presidentsales  marketing by eli lilly  co vice presidentsales  marketing by agouron pharmaceuticals inc rituxan development team leader by idec pharmaceuticals corp and directorglobal marketing planning by pfizer incshe also served on the board at aragon pharmaceuticals inc and seragon pharmaceuticals incshe received his undergraduate degree from the university of kentucky college of pharmacy and a doctorate degree from the university of kentucky college of pharmacy current positions of carol giltner gallagher phd  nametitle since anaptysbio incbiotechnology  medical research executive chairman  atara biotherapeutics incbiotechnology  medical research lead independent director millendo therapeutics inc chairman sharp healthcare director sanford burnham prebys medical discovery institute trustee cleave biosciences inc director new enterprise associates llc partner  holdings of carol giltner gallagher phd  nameequitiesvaluation anaptysbio inc anab biotechnology  medical research  usd atara biotherapeutics inc atra biotechnology  medical research  usd carol giltner gallagher phd personal network  namelinked companies james n topper anaptysbio incmillendo therapeutics inc beth c seidenberg atara biotherapeutics inc heather d turner atara biotherapeutics inc joel s marcus atara biotherapeutics inc eric l dobmeier atara biotherapeutics inc william k heiden atara biotherapeutics inc john f mcgrath atara biotherapeutics inc issac e ciechanover atara biotherapeutics inc matthew k fust atara biotherapeutics inc mitchall g clark atara biotherapeutics inc most read news   charles schwab  lowfee blackrock funds reel in cash but earnings disappoint djcharles scharf  bank of new york mellon names former visa executive scharf ceo and chairman  philip green  youre hired  uk apprentice star brady to chair philip greens company djrupert murdoch  tesla names james murdoch and linda johnson rice to board  update djjames murdoch  tesla names james murdoch and linda johnson to board of directors djmark light  top company news of the day djnelson peltz  peltz goes on offense in break from form  wsj  david henry  didnt pay your macys bill expect a text from citigroup djmark light  top company news of the day djnelson peltz  peltz seeks pg board seat  wsj more news   people and ownership     advertisement carol giltner gallagher phd  connections  anaptysbio inc james n topper macrogenics inc matthew k fust ultragenyx pharmaceutical inc matthew k fust dermira inc matthew k fust alexandria real estate equities inc joel s marcus amag pharmaceuticals inc william k heiden versartis inc eric l dobmeier seattle genetics inc eric l dobmeier stemline therapeutics inc eric l dobmeier epizyme inc beth c seidenberg iti inc joel s marcus atara biotherapeutics inc beth c seidenbergheather d turnerjoel s marcuseric l dobmeierwilliam k heidenjohn f mcgrathissac e ciechanovermatthew k fustmitchall g clark tesaro inc beth c seidenberg the partnership for new york city joel s marcus alexandria equities llc joel s marcus progyny inc beth c seidenberg frazier management llc james n topper national september  memorial  museum at the world trade joel s marcus nyu schack institute of real estate joel s marcus aptinyx inc james n topper popular business leaders  bernard arnault mary barra lloyd blankfein michael bloomberg yannick bollor� warren buffett antony burgmans jeanpaul clozel gary cohn jamie dimon ralph dommermuth sebastian ebel john edwards david einhorn jeff fettig mark fields carlos ghosn terry gou david henry carl icahn r johnson michel landel daniel loeb jack ma marissa mayer lakshmi mittal leslie moonves rupert murdoch elon musk peter nicholas john paulson nelson peltz georges plassat hasso plattner thomas rabe giuseppe recchi wolfgang reitzle urs rohner wilbur ross charles schwab igor sechin pascal soriot george soros rupert stadler bernard tapie john williamson thomas wilson dieter zetsche mark zuckerberg az business leaders traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners b�rse aktien kurse und nachrichtenbest tweets copyright �  surperformance all rights reserved slave carol giltner gallagher phd  biography log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east� more equities indexes dow jonessp nasdaq tsx compftse � more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd� more currencies commodities goldcrude oil wticrude oil brentsilverplatinum� more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    news    business leaders    business leaders biography business leaders latest newscompaniesmarketseconomy  forexcommoditiesinterest ratesbusiness leadersfinance professionalscalendarsectors homeall newsmost read newsbusiness leaders biography carol giltner gallagher phd age  public asset   usdlinked companies  anaptysbio inc  atara biotherapeutics inc summary  dr carol g gallagher is partner at new enterprise associates llc executive chairman at anaptysbio inc and chairman at millendo therapeutics incshe is on the board of directors at atara biotherapeutics inc sharp healthcare and sanford burnham prebys medical discovery institute dr gallagher was previously employed as venture partner by frazier management llc chairman by effector therapeutics inc president  chief executive officer by calistoga pharmaceuticals inc president  chief executive officer by metastatix inc svpcorporate development  commercial affairs by anadys pharmaceuticals inc vice presidentproduct planning by cancervax corp senior directoroncology marketing by biogen idec inc vice presidentsales  marketing by amgen inc vice presidentsales  marketing by eli lilly  co vice presidentsales  marketing by agouron pharmaceuticals inc rituxan development team leader by idec pharmaceuticals corp and directorglobal marketing planning by pfizer incshe also served on the board at aragon pharmaceuticals inc and seragon pharmaceuticals incshe received his undergraduate degree from the university of kentucky college of pharmacy and a doctorate degree from the university of kentucky college of pharmacy current positions of carol giltner gallagher phd  nametitle since anaptysbio incbiotechnology  medical research executive chairman  atara biotherapeutics incbiotechnology  medical research lead independent director millendo therapeutics inc chairman sharp healthcare director sanford burnham prebys medical discovery institute trustee cleave biosciences inc director new enterprise associates llc partner  holdings of carol giltner gallagher phd  nameequitiesvaluation anaptysbio inc anab biotechnology  medical research  usd atara biotherapeutics inc atra biotechnology  medical research  usd carol giltner gallagher phd personal network  namelinked companies james n topper anaptysbio incmillendo therapeutics inc beth c seidenberg atara biotherapeutics inc heather d turner atara biotherapeutics inc joel s marcus atara biotherapeutics inc eric l dobmeier atara biotherapeutics inc william k heiden atara biotherapeutics inc john f mcgrath atara biotherapeutics inc issac e ciechanover atara biotherapeutics inc matthew k fust atara biotherapeutics inc mitchall g clark atara biotherapeutics inc most read news   charles schwab  lowfee blackrock funds reel in cash but earnings disappoint djcharles scharf  bank of new york mellon names former visa executive scharf ceo and chairman  philip green  youre hired  uk apprentice star brady to chair philip greens company djrupert murdoch  tesla names james murdoch and linda johnson rice to board  update djjames murdoch  tesla names james murdoch and linda johnson to board of directors djmark light  top company news of the day djnelson peltz  peltz goes on offense in break from form  wsj  david henry  didnt pay your macys bill expect a text from citigroup djmark light  top company news of the day djnelson peltz  peltz seeks pg board seat  wsj more news   people and ownership     advertisement carol giltner gallagher phd  connections  anaptysbio inc james n topper macrogenics inc matthew k fust ultragenyx pharmaceutical inc matthew k fust dermira inc matthew k fust alexandria real estate equities inc joel s marcus amag pharmaceuticals inc william k heiden versartis inc eric l dobmeier seattle genetics inc eric l dobmeier stemline therapeutics inc eric l dobmeier epizyme inc beth c seidenberg iti inc joel s marcus atara biotherapeutics inc beth c seidenbergheather d turnerjoel s marcuseric l dobmeierwilliam k heidenjohn f mcgrathissac e ciechanovermatthew k fustmitchall g clark tesaro inc beth c seidenberg the partnership for new york city joel s marcus alexandria equities llc joel s marcus progyny inc beth c seidenberg frazier management llc james n topper national september  memorial  museum at the world trade joel s marcus nyu schack institute of real estate joel s marcus aptinyx inc james n topper popular business leaders  bernard arnault mary barra lloyd blankfein michael bloomberg yannick bollor� warren buffett antony burgmans jeanpaul clozel gary cohn jamie dimon ralph dommermuth sebastian ebel john edwards david einhorn jeff fettig mark fields carlos ghosn terry gou david henry carl icahn r johnson michel landel daniel loeb jack ma marissa mayer lakshmi mittal leslie moonves rupert murdoch elon musk peter nicholas john paulson nelson peltz georges plassat hasso plattner thomas rabe giuseppe recchi wolfgang reitzle urs rohner wilbur ross charles schwab igor sechin pascal soriot george soros rupert stadler bernard tapie john williamson thomas wilson dieter zetsche mark zuckerberg az business leaders traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners b�rse aktien kurse und nachrichtenbest tweets copyright �  surperformance all rights reserved slave insider trading  gallagher carol giltner  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  gallagher carol giltner select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm atara biotherapeutics inc atra gallagher carol giltnerdirector    direct view sale  pm atara biotherapeutics inc atra gallagher carol giltnerdirector    direct view sale  pm atara biotherapeutics inc atra gallagher carol giltnerdirector    direct view sale  pm atara biotherapeutics inc atra gallagher carol giltnerdirector    direct view sale  pm atara biotherapeutics inc atra gallagher carol giltnerdirector    direct view sale  pm atara biotherapeutics inc atra gallagher carol giltnerdirector    direct view purchase  pm atara biotherapeutics inc atra gallagher carol giltnerdirector    indirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view option award  pm na atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view option award  pm na atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view exercise  pm nana atara biotherapeutics inc atra gallagher carol giltnerdirector   direct view   secformcom all rights reserved archives        mon  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  carol giltner gallagher  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors carol giltner gallagher check out list of companies and businesses related to carol giltner gallagher find out carol giltner gallagher address and contact details view other people related to carol giltner gallagher  coworkers colleagues companions etc address  rutherford road carlsbad  ca companies related to carol giltner gallagher cikcompany namepositioncompany addressmicromet incvice president salesmarketin  corporate boulevard suite  rockville anaptysbio incdirector  pacific center court suite  san diego atara biotherapeutics incdirector  gateway blvd suite  south san francisco  carol giltner gallagher on the web persons related to carol giltner gallagher  micromet incnamepositioncitygroup plc londonadvent management iii l plondonadvent private equity fund iii a ltd partnershiplondonadvent private equity fund iii affiliateslondonadvent private equity fund iii b ltd partnershiplondonadvent private equity fund iii c ltd partnershiplondonadvent private equity fund iii d ltd partnershiplondonadvent private equity fund iii gmbh  co kglondonhazel m akersr vp general counsel carlsbadmatthias aldersrvp and general counsel carlsbadmatthias aldersvp and general counsel bethesdamatthias aldersvp  gc bethesdamatthias aldersvp general counsel bethesdamatthias aldersvp gc and secretary bethesdamatthias aldersvp gc and secretary rockvillesharon rose alvarezmastertonguernsey gy zdamgen inc owner thousand oaksarmstrong acquisition corpthousand oaksdebra j arnoldvp quality carlsbadpatrick baeuerlesvp chief scientific officer munichpatrick baeuerlesvp  cso bethesdapatrick baeuerlesvp cso gautingpatrick baeuerlesvp rd cso munichpatrick baeuerlesvp cso munichjerry benjamindirector londonjerry benjamindirector huntersvillejerry benjamindirector bethesdajerry benjamindirector bethesdajohn e berrimandirector munichjohn e berrimandirector bethesdajohn e berrimandirector cambridgejohn e berrimandirector bethesdajohn e berrimandirector rockvillerobert a bradwaythousand oaksmichael g carterdirector carlsbadmichael g carterdirector rockvillemichael g carterdirector bethesdamichael g carterdirector bethesdamichael g carterdirector carlsbadmichael g carterdirector bethesdascott davidthousand oakskapil dhingradirector tenaflykapil dhingradirector bethesdakapil dhingradirector rockvillejan fagerbergsvp  cmo bethesdajan fagerbergsvp chief medical officer munichjan fagerbergsvp chief medical officer munichjan fagerbergsvp chief medical officer munichcarol giltner gallaghervice president salesmarketin carlsbadguy gammonvice president clinical carlsbadcam l garnerdirector carlsbadulrich m grauevp and coo munichulrich m grauevp and coo munichandrew guilleguernsey gy zddavid f haledirector carlsbaddavid f haledirector rockvilledavid f haledirector san diegodavid f haledirector encinitassean e harperthousand oaksconnie helyarguernsey gy zdconnie helyarguernsey channel islandsjens henneckesvp business development munichjens henneckevp business development bethesdajens henneckesvp business development munchenjens henneckesvp business development munichjens henneckesvp business development munichchristian itinpresident and ceo munichchristian itinpresident  ceo bethesdachristian itinpresident ceo feldafingchristian itinpresident and ceo munichchristian itinpresident and ceo munichchristian itinmunichpeter johanndirector heidelburgpeter johanndirector heidelbergpeter johanndirector bethesdapeter johanndirector heidelbergpeter johanndirector bethesdapeter johanndirector heidelbergpeter johanndirector rockvillepeacock jonathanthousand oaksrobert lewis jonesvphuman resources carlsbadrobert e kissdirector carlsbadjames laforcedirector carlsbadwilliam r laruesrvp and cfo carlsbadjoseph m lobackisvp  chief commercial officer rockvillejohn p luffguernsey gy zdjohn p luffguernsey channel islandsmartin a mattinglyexec vp marketing  bus dev carlsbadbrian m mcnameethousand oaksgregor mirowsvp operations munichomega fund gp ltdguerney gy zdomega fund gp ltdguernsey channel islandsomega fund i lpguernsey gy zdomega fund i lpguernsey channel islandsomega fund iii gp ltdguernsey channel islandsomega fund iii gp lpguernsey channel islandsomega fund iii lpguernsey channel islandsomega fund management ltd owner guernsey gy zdomega fund management ltd owner guernsey channel islandsjonathan m peacockthousand oaksjohn petriccianisrvp medical  regulatory carlsbadbarclay a phillipsdirector carlsbadbarclay a phillipssvp cfo rockvillebarclay a phillipsdirector carlsbadbarclay a phillipssvp chief financial officer bethesdabarclay a phillipsdirector bethesdabarclay a phillipssvp cfo carlsbadbarclay a phillipssvp cfo bethesdamartha s prestonvp global regulatory affairs carlsbadcarsten reinhardtchief medical officer munichcarsten reinhardtsvp  cmo bethesdacarsten reinhardtsvp  cmo munichmark l reisenauersvp cco bethesdamark l reisenauersvp chief commercial officer bethesdamark l reisenauersvp chief commercial officer bethesdaivor roystondirector carlsbadsteven j ruhlvice president manufacturing carlsbadphillip m schneiderdirector carlsbadphillip m schneiderdirector bethesdachristopher p schnittkerchief financial officer carlsbadchristopher p schnittkerchief financial officer bethesdagail schoettlerdirector carlsbaddavid j scottthousand oaksharper seanthousand oakskevin w sharerthousand oakssigma holding ltdguernsey gy zdsigma holding ltdguernsey channel islandsjeffrey steven silvermanvp manufacturing operations carlsbadjoseph p slatterydirector rockvillejoseph p slatterydirector gaithersburgjoseph p slatterydirector bethesdajoseph p slatterydirector bethesdajoseph p slatterydirector bethesdajoseph p slatterydirector bethesdaotello stampacchiadirector  genevaotello stampacchiadirector george town grand caymanotello stampacchiadirector bethesdaotello stampacchiadirector  genevaotello stampacchiadirector bostonepps dennis e vanvp research carlsbaddonald a zelmchief financial officer bethesdapersons related to carol giltner gallagher  anaptysbio incnamepositioncityavalon ventures vii l pla jollagallagher carolsan diegogallagher carolsan diegonathan r everyseattlefhm v llcseattlefhm v lpseattlefhm vii llcseattlefhm vii lpseattlealan d frazierseattlefrazier healthcare v lp owner seattlefrazier healthcare viia lpseattlefrazier healthcare vii lp owner seattlecarol giltner gallagherdirector carlsbadsuria hamzasan diegosuria hamzasan diegolukatch heathsan diegolukatch heathsan diegolukatch heathesan diegopatrick j heronpalo altorenton hollingssan diegoread jsan diegoread jsan diegotopper jamessan diegotopper jamessan diegotopper jamessan diegoschmid johnsan diegokinsella kevinsan diegokinsella kevinsan diegokevin j kinsellasan diegomarco londeichief medical officer san diegonicholas lydondirector cambridgelondei marcosan diegomatthew moylechief scientific officer houstonnader j nainiseattlelydon nicholassan diegolydon nicksan diegolydon nicksan diegoas novo owner bagsvaerddominic piscitellichief financial officer san diegohollings rentondirector hoffman robertsan diegojohn p schmiddirector san diegojames a schoeneckdirector menlo parkhamza suriapresident ceo san diegosmart thomassan diegoaynechi tibasan diegostephen lawrence tomlinla jollajames n topperdirector seattlepersons related to carol giltner gallagher  atara biotherapeutics incnamepositioncityjames c blairprincetonjohn j cadeddupalo altoyoung j chungpalo altoisaac e ciechanoverchief executive officer brisbaneisaac e ciechanoverchief executive officer south san franciscomitchall g clarkevp  chief r  qa officer brisbanemitchall g clarkchief r  qa officer south san franciscodag ventures management v llc owner palo altodag ventures v lppalo altodag ventures vqp lppalo altoeric dobmeierdirector bothelldomain partners viii lp owner princetonbrian h doveyprincetondp viii associates lp owner princetonmatthew k fustdirector palo altomatthew k fustdirector brisbanematthew k fustdirector south san franciscocarol giltner gallagherdirector carlsbadcarol giltner gallagherdirector brisbanecarol giltner gallagherdirector south san franciscor thomas goodrichpalo altobrian k halakprincetonchristopher haqqevp rd  chief scientific of brisbanechristopher haqqchief medical officer south san franciscowilliam k heidendirector walthamkleiner perkins caufield  byers xv llc owner menlo parkkpcb xv associates llcmenlo parkkpcb xv founders fund llcmenlo parkjoel s marcusdirector joel s marcusdirector pasadenajoel s marcusdirector pasadenajohn mcgrathevp  chief financial officer sunnyvalejohn mcgrathchief financial officer brisbanejohn mcgrathchief financial officer south san franciscojoe newellchief tech operations officer south san francisconicholas k pianimpalo altoderrell portersvp head of global commercial south san franciscokathleen k schoemakerprincetonbeth c seidenbergdirector beth c seidenbergdirector menlo parkgad soferevp  chief strategy officer brisbanegad sofferchief operating officer brisbanegad sofferchief operating officer south san franciscojesse i treuprincetonheather d turnerevp general counsel  sec san diegonicole vitulloprincetoneckard weberbrisbaneeckard weberdirector south san franciscogreg williamspalo alto nea welcomes carol gallagher as partner  nea  new enterprise associates skip to navigation skip to content about portfolio companies resources talent technology briefings programs  events team history news contact login see our facebook see our twitter see our linkedin search search search nea return home toggle nav press release nea welcomes carol gallagher as partner october   veteran entrepreneur operator and strategist brings deep biopharma industry experience menlo park ca – october   – new enterprise associates inc nea a global venture capital firm today announced that carol gallagher pharm d has joined the firm as a partner in its menlo park office dr gallagher who brings to nea more than  years of experience in drug development commercialization and strategic leadership will invest in biopharma opportunities across a range of therapeutic areas and stages of development “we are delighted to welcome carol to the team” said david mott general partner and head of nea’s healthcare practice “many of us have had the pleasure of working with carol over the years witnessing firsthand the passion business acumen and drug development and commercial expertise that she brings to each endeavor—and we’re thrilled she’ll now be applying those strengths as a member of nea’s investing practice her proven track record as an operator and entrepreneur coupled with her extensive network across the healthcare industry will also make her a highly valued resource to our portfolio” in addition to her role at nea dr gallagher is the chairman of atara biotherapeutics and anaptysbio and a director of atterocor until recently she served as the chairman of effector therapeutics a director at aragon pharmaceuticals acquired by johnson  johnson in  and a venture partner with frazier healthcare dr gallagher was president and ceo of venturebacked calistoga pharmaceuticals where she led the development of the company’s novel pik inhibitor recently approved by the fda for multiple indications in chronic lymphocytic leukemia and lymphoma and successful acquisition by gilead sciences in    “the ‘business of science’ has always been deeply compelling to me—it’s been a driving force throughout my career and i am very excited to continue that journey with nea” said dr gallagher “having worked closely with numerous partners at the firm over the years it’s clear that nea’s success in healthcare is fueled by a very similar mindset—the team has an extraordinary enthusiasm for the sector and is deeply committed to transforming healthcare and improving patients’ lives” prior to joining calistoga dr gallagher served as president and ceo of metastatix earlier in her career she held a variety of senior management and commercial roles at cancervax anadys pharmaceuticals biogen idec pfizer agouron pharmaceuticals amgen and eli lilly she attended vanderbilt university and received bachelor of science and doctor of pharmacy degrees from the college of pharmacy at the university of kentucky   about nea nea is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages sectors and geographies with more than  billion in committed capital the firm invests in information technology and healthcare companies at all stages in a company’s lifecycle from seed stage through ipo nea’s long track record of successful investing includes more than  portfolio company ipos and more than  acquisitions for additional information visit wwwneacom news and media limited partner login employee loginopens in new window portfolio company login contact us see our facebook see our twitter see our linkedin copyright  nea terms  conditions privacy policy stock screener  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets closedsp  dow  insider transactionsdefault criteriainsider  restricted shareholder transactions of  resultsresults were generated a few mins ago pricing data is updated frequently currency in usdsymboldatesharesproceedstransaction detailsatraautomatic sale at  per shareatranaacquisition non open market at  per shareatraautomatic sale at  per shareatranaoption execute at  per shareatraautomatic sale at  per shareatranaoption execute at  per shareanabnaacquisition non open market at  per shareatranaacquisition non open market at  per shareatraautomatic sale at  per shareatranaoption execute at  per shareatranaoption execute at  per shareatraautomatic sale at    per shareatranaoption execute at  per shareatraautomatic sale at    per shareatranaoption execute at  per shareatraautomatic sale at    per shareatranaoption execute at  per shareatraautomatic sale at    per shareatraautomatic sale at    per shareatraautomatic sale at    per shareatraautomatic sale at    per shareatrasale at    per shareatraautomatic sale at    per shareatranaoption execute at  per sharegoogle parent alphabet reports lower profit on big eu finecnbcobamacare is hurting these people—and congress is doing nothing about ityahoo financechina is crushing american tech titansyahoo finance videoyahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated